Standard InChI: InChI=1S/C34H35N5O4/c40-31-27(18-22-10-3-1-4-11-22)37-33(42)30-16-9-17-39(30)34(43)29(19-23-12-5-2-6-13-23)38-32(41)28(36-31)20-24-21-35-26-15-8-7-14-25(24)26/h1-8,10-15,21,27-30,35H,9,16-20H2,(H,36,40)(H,37,42)(H,38,41)/t27-,28+,29-,30+/m0/s1
1.Dolle RE, Michaut M, Martinez-Teipel B, Seida PR, Ajello CW, Muller AL, DeHaven RN, Carroll PJ.. (2009) Nascent structure-activity relationship study of a diastereomeric series of kappa opioid receptor antagonists derived from CJ-15,208., 19 (13):[PMID:19464172][10.1016/j.bmcl.2009.04.105]
2.Carroll FI, Carlezon WA.. (2013) Development of κ opioid receptor antagonists., 56 (6):[PMID:23360448][10.1021/jm301783x]
3.Smith MT, Kong D, Kuo A, Imam MZ, Williams CM.. (2022) Analgesic Opioid Ligand Discovery Based on Nonmorphinan Scaffolds Derived from Natural Sources., 65 (3.0):[PMID:34995453][10.1021/acs.jmedchem.0c01915]